| NCT | Trial Name | # of Centers |
|---|
NCT01222754 |
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas | 6 |
NCT00302159 |
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors | 3 |
NCT00598351 |
Natural History Study of Patients With Neurofibromatosis Type 2 | 1 |
NCT00880061 |
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma | 1 |
NCT00995007 |
A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas | 1 |
NCT01117168 |
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group | 1 |
NCT01222728 |
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients | 1 |
NCT00001595 |
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders | 1 |
NCT00001686 |
Evaluation, Treatment, and Natural History of Children With Cancer | 1 |
NCT00009035 |
Natural History of Patients With Brain and Spinal Cord Tumors | 1 |
NCT00054756 |
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities | 1 |
NCT00060541 |
Evaluation and Treatment of Neurosurgical Disorders | 1 |
NCT00267865 |
Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma | 1 |
NCT01222780 |
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer | 1 |
NCT01386450 |
AZD6244 in Children With Low-Grade Gliomas | 1 |
NCT01434602 |
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas | 1 |
NCT01445288 |
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors | 1 |
NCT01445483 |
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases | 1 |
NCT01454596 |
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII | 1 |
NCT01679743 |
GRN1005 for Brain Metastases From Breast or Lung Cancer | 1 |
NCT01875601 |
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | 1 |
NCT02069080 |
Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor | 1 |
NCT02108002 |
Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only) | 1 |
NCT02153957 |
Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors | 1 |
NCT02179515 |
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) | 1 |
NCT02203526 |
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma | 1 |
NCT02390752 |
Phase I/II Trial of PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) | 1 |
NCT02644512 |
Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas | 1 |
NCT02709226 |
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma | 1 |
NCT01174121 |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | 1 |
